Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mildly Impaired Renal Function”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04776187
What this trial is testing

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

Who this might be right for
Nephrogenic Fibrosing Dermopathy
The Central Hospital of Lishui City 600
Not applicableStudy completedNCT07272733
What this trial is testing

Early Detection, Remote Augmented Reality Combined Rehabilitation Therapy, and Translational Therapy for Patients With Chronic Kidney Disease and Cognitive Disorder

Who this might be right for
Chronic Kidney Disease (Stages 3b-5)Mild Cognitive Disorder
Taipei Medical University Hospital 15
Early research (Phase 1)Ended earlyNCT02679131
What this trial is testing

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Who this might be right for
Relapsed/Refractory Solid Tumors/Hematological Malignancies
Acrotech Biopharma Inc. 18
Not applicableLooking for participantsNCT03547414
What this trial is testing

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

Who this might be right for
Acute Kidney InjurySeptic Shock
Centre Hospitalier Universitaire, Amiens 110
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Early research (Phase 1)Study completedNCT01934166
What this trial is testing

Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
H. Lundbeck A/S 32
Early research (Phase 1)WithdrawnNCT05541159
What this trial is testing

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT01763190
What this trial is testing

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Bristol-Myers Squibb 36
Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Post-approval studies (Phase 4)Study completedNCT02178306
What this trial is testing

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

Who this might be right for
Hypertension
Boehringer Ingelheim 82
Early research (Phase 1)Study completedNCT01613690
What this trial is testing

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT02219516
What this trial is testing

Mild, Moderate and Severe Renal Impairment Study

Who this might be right for
Gout
Ardea Biosciences, Inc. 31
Early research (Phase 1)Study completedNCT04142970
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Who this might be right for
Chronic Renal Impairment
Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Not applicableLooking for participantsNCT05655325
What this trial is testing

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

Who this might be right for
Mild Cognitive ImpairmentChronic Kidney Diseases
Columbia University 144
Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Not applicableStudy completedNCT00354588
What this trial is testing

Arterial Stiffness, Wave Reflections and Renal Failure

Who this might be right for
Chronic Renal FailureArterial StiffnessArterial Wave Reflections
Klinikum Wels-Grieskirchen 115
Early research (Phase 1)Study completedNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 35
Early research (Phase 1)Study completedNCT02653014
What this trial is testing

Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
KBP Biosciences 26
Early research (Phase 1)Study completedNCT02807077
What this trial is testing

PK of Pacritinib in Patients With Mild, Moderate, Severe Renal Impairment and ESRD Compared to Healthy Subjects

Who this might be right for
Myelofibrosis
CTI BioPharma 40
Post-approval studies (Phase 4)Study completedNCT00369382
What this trial is testing

Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

Who this might be right for
Graft RejectionKidney Failure
Wyeth is now a wholly owned subsidiary of Pfizer 121
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation